Revolutionizing bioanalysis with high-resolution mass spec
Shownotes
In this episode of Data in Biotech, host Ross Katz sits down with Eshani Galermo, Staff Scientist at SCIEX, to explore the next generation of mass spectrometry in pharma and biopharma. Eshani explains how innovations like the ZenoTOF 8600 are redefining sensitivity, selectivity, and workflow efficiency in bioanalytical chemistry. Discover how high-resolution accurate mass (HRAM) systems are unlocking new capabilities in drug discovery, clinical studies, and regulatory science.
What you'll learn in this episode:
>> Why traditional mass spectrometry falls short in modern bioanalysis
>> How the ZenoTOF 8600 enhances sensitivity and reduces sample volume needs
>> The role of high-resolution systems in detecting complex drug metabolites
>> How automation tools are streamlining workflows for bioanalytical scientists
>> The complementary role of AI and ML in mass spec data analysis
Meet our guest
Eshani Galermo is a Staff Scientist at SCIEX, where she leads global strategic marketing initiatives for pharma and biopharma quant applications. With deep expertise in bioanalytical chemistry and mass spectrometry, she has held multiple scientific roles across SCIEX, Emery Pharma, and Genentech.
About the host
Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation.
Connect with Our Guest:
Connect with Us:
- Follow the podcast for more insightful discussions on the latest in biotech and data science.
- Subscribe and leave a review if you enjoyed this episode!
- Connect with Ross Katz on LinkedIn
Sponsored by…
This episode is brought to you by CorrDyn, the leader in data-driven solutions for biotech and healthcare. Discover how CorrDyn is helping organizations turn data into breakthroughs at CorrDyn.